Highlights
Imfinzi cancer combo falls short in DANUBE trial
Despite the setback, AstraZeneca says that it “remains committed to addressing unmet needs in bladder cancer."
Widowhood Tied to More Rapid Cognitive Decline Among Seniors
FRIDAY, March 6, 2020 -- Widowhood accelerates cognitive decline among those at risk for Alzheimer disease, according to
California Cruise Ship Passengers Await COVID-19 Test Results
FRIDAY, March 6, 2020 -- Thousands of passengers stranded on a cruise ship linked to California's first COVID-19 dea
Long-Term Endurance Exercise Tied to Aortic Enlargement
FRIDAY, March 6, 2020 -- Clinically relevant aortic dilatation is common among aging endurance athletes, according to a
Bariatric Surgery Outcomes Similar Regardless of Obesity Onset
FRIDAY, March 6, 2020 -- The treatment benefits of bariatric surgery in adults are similar regardless of early- or adult
Hospital Infection Control Can Prevent COVID-19 Transmission
FRIDAY, March 6, 2020 -- Appropriate hospital infection control measures can protect health care workers from novel coro
Increase Seen in Melatonin Secretion After Cataract Surgery
FRIDAY, March 6, 2020 -- Cataract surgery seems to increase melatonin secretion in adults aged 60 years or older, accord
Scottish economy to benefit from biomedical cluster
A project to grow the Tay Cities biomedical cluster of life sciences companies will generate hundreds of millions of pou
Post-surgery chemo halves risk of recurring rare kidney cancer
71% of patients given chemotherapy survived for three years or more after joining the trial without their disease coming
New partnership will ‘reduce risk and improve patient safety’
Forescout Technologies, a specialist in device visibility and control, has announced a strategic partnership with dedica
Biosimilars in the age of patient-centricity
In 2020, nearly all pharmaceutical companies claim to be ‘patient-centric’. In fact, some companies have
FDA accepts application for Mylan’s bevacizumab biosimilar
US-based drugmaker Mylan announced on 27 February 2020 that the US Food and Drug Administration (FDA) had accepted it